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Abstract
Background: Mutation in SPINK5 causes Netherton syndrome, a rare recessive skin disease that
is accompanied by severe atopic manifestations including atopic dermatitis, allergic rhinitis, asthma,
high serum IgE and hypereosinophilia. Recently, single nucleotide polymorphism (SNP) of the
SPINK5 was shown to be significantly associated with atopy, atopic dermatitis, asthma, and total
serum IgE. In order to determine the role of the SPINK5 in the development of asthma, a case-
control study including 669 asthma patients and 711 healthy controls in Han Chinese was
conducted.
Methods:  Using PCR-RFLP assay, we genotyped one promoter SNP, -206G>A, and four
nonsynonymous SNPs, 1103A>G (Asn368Ser), 1156G>A (Asp386Asn), 1258G>A (Glu420Lys),
and 2475G>T (Glu825Asp). Also, we analyzed the functional significance of -206G>A using the
luciferase reporter assay and electrophoresis mobility shift assay.
Results: we found that the G allele at SNP -206G>A was associated with increased asthma
susceptibility in our study population (p = 0.002, odds ratio 1.34, 95% confidence interval 1.11–
1.60). There was no significant association between any of four nonsynonymous SNPs and asthma.
The A allele at -206G>A has a significantly higher transcriptional activity than the G allele.
Electrophoresis mobility shift assay also showed a significantly higher binding efficiency of nuclear
protein to the A allele compared with the G allele.
Conclusion: Our findings indicate that the -206G>A polymorphism in the SPINK5 is associated
with asthma susceptibility in a Chinese Han population.
Background
Asthma, a chronic inflammatory disease of the airway, is
caused by inappropriate immune responses to environ-
mental allergens. The individual variation in predisposi-
tion to asthma is genetically determined [1,2]. It is
characterized prominently by an elevated production of
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immunoglobin E (IgE) and TH2 cytokines, a remarkable
increase in recruitment of mast cells, eosinophils, and
basophils to the airway epithelium as well as airway
hyper-responsiveness (AHR) [3-5]. Pathogenesis of
asthma is considered to be multifactorial, involving com-
plex interactions between genetic and environmental fac-
tors [6]. Recently, considerable effort has been directed
toward a better understanding of the genetic factors
involved in the development of asthma and other allergic
diseases. A number of asthma susceptibility genes have
been identified through genome-wide screens and candi-
date gene studies [7,8]. Moreover, some genes that are
responsible for monogenic disorders were found to con-
tribute to manifestations of similar phenotype in complex
diseases. For example, while mutations in SPINK5, causes
Netherton syndrome, a rare autosomal recessive disorder,
SPINK5  also plays a role in common atopic diseases
[9,10].
The  SPINK5  encodes the lymphoepithelial Kazal-type-
related inhibitor (LEKTI), a 15-domain serine protease
inhibitor, and is located on chromosome 5q31-32[11], a
region repeatedly found to be linked to asthma [12-15].
Loss of function mutations in the SPINK5  gene cause
Netherton syndrome, characterized by congenital ichthy-
osis with defective cornification, and severe atopic mani-
festations including atopic dermatitis, allergic rhinitis,
asthma, markedly elevated serum IgE and hypereosi-
nophilia [9]. Subsequently, Walley et al. identified 32
SNPs within the coding region of the SPINK5  gene,
including six SNPs that result in amino acid changes in the
encoded protein. They showed an association between the
SNP G1258A (Glu420Lys) and atopy, atopic dermatitis,
elevated serum IgE levels and asthma [10]. However, the
results were not consistently replicated in other studies
[16-20]. To test whether SPINK5 plays a role in the devel-
opment of asthma in Han Chinese, a case-control study
was conducted on 669 unrelated asthma patients and 711
healthy control subjects recruited in a Han Chinese popu-
lation. Four nonsynonymous SNPs, 1103A>G
(Asn368Ser), 1156G>A (Asp386Asn), 1258G>A
(Glu420Lys), and 2475G>T (Glu825Asp), were geno-
typed, and no statistically significant difference in the gen-
otype and allele distribution for any of four
nonsynonymous SNPs was observed between the patients
and control subjects. However, we found that the SNP -
206G>A in promoter region was associated with asthma
susceptibility. Furthermore, we analyzed the functional
significance of -206G>A using luciferase reporter gene
assay and electrophoretic mobility shift assay.
Methods
Subjects
Chinese subjects of exclusively Han nationality (n = 1380)
were included in this case-control study. A total of 669
patients with clinically manifested asthma, 317 males and
352 females were recruited from Weifang Asthma Hospi-
tal and Shandong Provincial Hospital from 2004 to 2009.
The extended medical history, including occurrence and
duration of wheezing symptoms, was recorded for each
patient. Unrelated, random-sampled controls, 349 males
and 362 females had no symptoms of any atopic, lung
and skin diseases and had no familial history of asthma/
atopy. Clinical and demographic characteristics of the
patients and controls are summarized in Table 1. Blood
samples were obtained from all participants with
informed consent. Genomic DNA was extracted from
peripheral blood leukocytes by a standard salting-out
method. The study protocol was approved by the ethics
review committee for human studies at School of Medi-
cine, Shandong University.
SNP Genotyping
Five SNPs, one promoter SNP, -206G>A (transcription
start site as +1), four nonsynonymous SNPs, 1103A>G
(Asn368Ser), 1156G>A (Asp386Asn), 1258G>A
(Glu420Lys), and 2475G>T (Glu825Asp), were geno-
typed by PCR-RFLP assay. DNA fragments containing pol-
ymorphic sites were amplified, and the primer sequences
are shown in Table 2. PCR amplification was performed in
a total volume of 25 μl solution containing 50 ng of
genomic DNA, 200 μM of each dNTP (mixture of dATP,
dTTP, dCTP, dGTP), 0.2 μM of each primer, 1.5 mM of
MgCl2, 10 mM of Tris-HCL (pH 8.3) and 1 U of Taq DNA
polymerase. Cycling conditions included an initial dena-
turation at 94°C for 5 minutes followed by 35 cycles at
94°C for 40 seconds, 55°C for 40 seconds, 72°C for 60
seconds, and a final extension at 72°C for 10 minutes.
PCR products were digested with locus-specific restriction
enzymes (Table 2). Digestion products were separated on
2% agarose gel and visualized by ethidium bromide stain-
ing.
Luciferase assay
Two luciferase reporter constructs, pGL3/-206G and
pGL3/-206A, were generated by PCR combining with
restriction digestion. The transcription start site of SPINK5
was according to the ensemble website http://
Table 1: Clinical and demographic characteristics of the patients 
and controls
Characteristic Patients Controls
No. of subjects 669 711
Age:mean (range) 41.27(14–73) 44.19(18–68)
Sex (male/Female) 317/352 349/362
FVC (%predicted) 66.9 ± 15.7 79.4 ± 18.4
FEV1(%predicted) 57.2 ± 16.6 83.8 ± 13.9
% changes of FEV1 by bronchodilator 26.8 ± 13.7 4.7 ± 3.6
FVC: forced vital capacity; FEV1: forced expiratory volume in 1s.BMC Medical Genetics 2009, 10:59 http://www.biomedcentral.com/1471-2350/10/59
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www.ensembl.org. Briefly, a fragment of 487 bp in the
SPINK5  promoter corresponding to -355 to +132 was
amplified from two individuals, who are homozygous for
-206G and -206A, using primers 5'-acgagctccccacttatgaag-
ggagt-3' and 5'-ccgctcgagtggcaagaggcttagatt-3', which
incorporate specific cleavage sequences for restriction
endonucleases SacI and XhoI, respectively. The amplified
PCR products were digested with SacI and XhoI, and the
cleaved product was cloned into promoterless pGL3-basic
plasmid (Promega). Plasmid constructs were verified by
direct sequencing analysis. Plasmid DNA was prepared
using plasmid mega kit (Omega) for further transfection.
Luciferase activity was measured using the Dual Luciferase
Reporter Assay System (Promega). Briefly, COS-7 cells
and HeLa cells were cultured in DMEM (Invitrogen) sup-
plemented with 10% fetal bovine serum, 100 IU/ml pen-
icillin, and 100 ug/ml streptomycin at 37°C in an
atmosphere of 5% CO2. Cells, 5 × 104/well, were inocu-
lated in a 24-well plate and cultured for 24 h before trans-
fection. The subconfluent cells were cotransfected with 1
μg of each construct (pGL3/Basic, pGL3/-206G and pGL3/
-206A) and 0.04 μg of pRL-TK vector, an internal control
for transfection efficiency, using Lipofectamine 2000
transfection reagent (Invitrogen). Thirty-six hours after
transfection, cells were harvested and lysed with passive
lysis buffer (Promega) according to the manufacturer's
instructions. Luciferase activity was measured using a
Microplate luminometer (3700) and normalized using
the activity of the Renilla luciferase. The relative luciferase
activity of the SPINK5 reporter construct was represented
as the ratio of the firefly luciferase activity to that of
Renilla. Each experiment was repeated three times, and
each sample was studied in triplicate.
Promoter database analysis
Allele specific transcription factor binding sites were iden-
tified using MatInspector software http://www.genom
atix.de/products/index.html
Electrophoretic Mobility Shift Assay (EMSA)
EMSA was performed as described previously [21]. Briefly,
nuclear proteins were extracted from HeLa cells using the
NE-PER nuclear and cytoplasmic extraction reagents
according to the manufacturer's protocol (Pierce, Rock-
ford, IL). The sense-strand sequences of -216A probe (con-
taining GATA binding site) and -216G probe (without
GATA binding site, as a competitor) were 5'-GTTCT-
GGGGGAGATACCATGAAAGA-3' and 5'-GTTCT-
GGGGGAGGTACCATGAAAGA-3', respectively. The
oligonucleotides of -216A probe and their complemen-
tary strand were annealed and end-labeled with digoxin
using T4 polynucleotide kinase. DIG-labeled probes were
incubated with or without 5 μg HeLa nuclear extracts for
30 min at room temperature and separated on a 6% non-
denaturing polyacrylamide gel with 0.5× TBE running
buffer. DNA-protein complexes were electroblotted onto
nylon membrane and the band shift was visualized
according to the user's manual for DIG Gel Shift Kit. For
the competition assay, nuclear extracts were incubated
with 25 or 50-fold amount of unlabeled probes for 15
min prior to adding labeled probe.
Statistical analysis
Allele carrier frequency was defined as the percentage of
the individuals carrying the allele among the total of the
individuals. Each SNP was evaluated for Hardy-Weinberg
equilibrium using a χ2 goodness of fit test. The asthma
patients and healthy controls were compared using the
case-control association analysis. Fisher's exact test was
used to compare the discrete variables between asthma
patients and healthy controls. The allele and genotype fre-
quencies, odds ratios (ORs) with 95% confidence inter-
vals (95%CI), and significance values were analyzed using
SPSS software for Windows (version 13; SPSS Inc, Chi-
cago, IL). Pairwise linkage disequilibrium (LD) was meas-
ured using the online SHEsis software http://
202.120.7.14/analysis/myAnalysis.php. The luciferase
reporter assay data were evaluated using a non-parametric
Table 2: PCR-RFLP analysis of the SPINK5 gene SNPs
Polymorphic Site Primers PCR products Restriction enzyme
-206 G>A 5'-TCTGCCTGCTCCAACTAA-3'
5'-CACTGACACTGTGGCTATCTT-3'
674 bp Kpn I
1103A>G (Asn368Ser) 5'-TCTGCCAATGTAGATGTT-3'
5'-CTCTAATGACTCCCAAGC-3'
670 bp Bts I
1156G>A (Asp386Asn) As above 670 bp Mbo I
1258G>A (Glu420Lys) 5'-TTTTAGCCAAGCAGAAGAAG-3'
5'-CAGTTTTAAGGAATGCACGT-3
177 bp Hinf I
2475G>T(Glu825Asp) 5'-TGGGGAACTGAAGAGCA-3'
5'-GGGACATTATTTTGCCTATC-3'
688 bp BstF5IBMC Medical Genetics 2009, 10:59 http://www.biomedcentral.com/1471-2350/10/59
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Mann-Whitney test (two-tailed). Statistical analysis was
performed with the SPSS 13.0 software. Power calculation
was performed using the computer program CaTS power
calculator to evaluate the type II error [22]. A p-value less
than 0.05 were considered statistically significant.
Results
Association of SPINK5 SNPs and haplotypes with asthma
Five SNPs genotyped in this study were chosen based on
their putative function, four of which were nonsynony-
mous substitutions, one from the promoter region. Geno-
type and allele frequencies of each SNP are shown in
Table 3. The distributions of five SNPs were in agreement
with Hardy-Weinberg equilibrium (P > 0.05) in both
asthma patients and healthy controls. To test the associa-
tion between each locus and asthma, we compared differ-
ences in allele frequency and genotype distribution of
each polymorphism between case and control subjects.
We found that the G allele of SNP -206 G>A was signifi-
cantly more common among patients with asthma than
among the controls (P = 0.002, OR 1.34; 95% CI: 1.11–
1.60). This elevated risk associated with G allele remains
significant even after adjusted by Bonferroni correction
(adjusted P = 0.01). This result suggested that SNP -
206G>A in the SPINK5 promoter region was significantly
associated with asthma in our Chinese cohort. On the
other hand, no statistically significant associations
between four nonsynonymous SPINK5 SNPs and asthma
were observed. With our sample size and with the alpha
level set at 0.05, there is at least 80% power for detection
of OR ≥1.3 for each of these four SNPs.
To better understand the relationship between the five
SNPs in SPINK5, linkage disequilibrium analysis was
assessed. There is significant linkage disequilibrium
between the SNPs (Table 4). We further analyzed the hap-
lotype structure, and identified seven common haplo-
types (Table 5). The frequency of the A-G-A-G-G
haplotype (haplotype 3) in the control group was 16.8%
and that in affected individuals was 11.7%. The difference
was statistically significant (P = 0.043).
-206G>A polymorphism is associated with differential 
transcription activity
The functional significance of -206G>A polymorphism in
transcription was explored using MatInspector software.
The G to A substitution at position -206 is predicted to
generate a GATA-3 transcription factor binding site (5'-
GATA-3'). To determine the effect of -206G>A polymor-
phism on promoter activity, allele-specific constructs,
pGL3/-206G, and pGL3/-206A, were generated, and tran-
siently expressed in COS-7 cells and HeLa cells. Luciferase
activity in cell extracts was analyzed 36 hours after trans-
fection and was standardized against internal control
Table 3: Genotype and allele frequencies of the SPINK5 SNPs in patients and controls
SNPs Genotype/allele Controls(%) Patients (%) Odds ratio (95% CI) PP *
-206 G>A AA 48 (6.75) 31 (4.63) 1.00
AG 243(34.18) 192 (28.70) 1.22(0.75–2.00)
GG 420(59.07) 446(66.67) 1.64(1.03–2.63) 0.01 0.05
A 339 (23.84) 254(18.98) 1.00
G 1083(76.16) 1084(81.02) 1.34(1.11–1.60) 0.002 0.01
1103A>G AA 74(18.05) 92(21.80) 1.00
AG 201(49.02) 192(45.50) 0.77(0.53–1.11)
GG 135(32.93) 138(32.70) 0.82(0.56–1.21) 0.365
A 349(42.56) 376(44.55) 1.00
G 471(57.44) 468(55.45) 0.92(0.76–1.12) 0.429
1156G>A GG 110(26.83) 111(26.30) 1.00
GA 201(49.02) 192(45.50) 0.95(0.68–1.32)
AA 99(24.15) 119(28.20) 1.19(0.82–1.73) 0.392
G 421(51.34) 414(49.05) 1.00
A 399(48.64) 430(50.95) 1.10(0.90–1.33) 0.352
1258G>A GG 174(42.44) 169(40.05) 1.00
GA 199(48.54) 201(47.63) 1.04(0.78–1.39)
AA 37(9.02) 52(12.32) 1.45(0.90–2.34) 0.295
G 547(66.71) 539(63.86) 1.00
A 273(33.29) 305(36.14) 1.13(0.93–1.39) 0.236
2475G>T GG 169(40.05) 191(46.59) 1.00
GT 201(47.63) 169(41.22) 0.97(0.74–1.32)
TT 52(12.32) 50(12.20) 1.07(0.69–1.65) 0.932
G 539(63.86) 551(67.20) 1.00
T 305(36.14) 269(32.80) 1.02(0.83–1.25) 0.835
P* indicates adjusting after Bonferroni correctionBMC Medical Genetics 2009, 10:59 http://www.biomedcentral.com/1471-2350/10/59
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Renilla activity. Results indicated that the -206G construct
showed a significant decrease in luciferase reporter activity
compared with the -206A construct (p = 0.002 and p =
0.0002 for COS7 and HeLa cells, respectively, Fig. 1).
These results suggested that the -206G allele might render
a decreased transcriptional activity of the SPINK5 in vivo.
-206G>A polymorphism is associated with differential 
binding by nuclear proteins
To further determine the requirement of the GATA bind-
ing site for the transcription regulation of SPINK5, EMSA
was conducted to test the binding efficiency of nuclear
proteins from the HeLa cells to the -216A probe. As shown
in Figure 2, a retarded band (a DNA-protein complex) was
observed in the presence of nuclear extracts (lane 2). The
competition assay with the unlabelled oligonucleotides
demonstrated that the DNA-protein complex was signifi-
cantly competed by 25- and 50-fold amount of unlabeled
-206A probe (lanes 3 and 4), but not by the same amount
of -216G probes (Lanes 5 and 6). These results indicate
that the -216A probe containing the GATA binding site
specifically binds with endogenous GATA transcription
factor. Creation of the GATA binding site by -216A allele
probably contributes to an enhanced SPINK5 transcrip-
tion.
Discussion
Because Netherton syndrome exhibits allergic phenotype,
it is reasonable to speculate that SPINK5, which is
mutated in Netherton syndrome, may act as a candidate
gene for asthma and other allergic diseases [9]. An exten-
sive search for single nucleotide polymorphisms in the
SPINK5 led to the identification of a number of SNPs,
including six nonsynonymous SNPs in coding region that
might perturb its immune function. Subsequent genotyp-
ing of three nonsynonymous SNPs, A1103G, G1156A and
G1258A in two independent panels of British families
showed a significant association between SNP G1258A
(Glu420Lys) and atopy, atopic dermatitis, elevated serum
IgE levels and asthma [10]. This association was con-
firmed in a large German population and two Japanese
populations [16-18]. Kato et al analyzed eight SNPs in
exon 13 and 14 of the SPINK5  including G1258A
(Glu420Lys), and found a positive association of seven
SNPs with atopic dermatitis in a Japanese study sample
using a case-control study design [16]. Nishio et al sur-
veyed five of six previously reported nonsynonymous
SPINK5  SNPs in Japanese atopic families identified
through asthmatic children or subjects with atopic derma-
titis and found that SPINK5 was associated with develop-
ment of atopic dermatitis but not asthma [17]. Kabesch M
et al. analyzed G1258A (Glu420Lys) in a German popula-
tion of school children, and found its association with
asthma as well as a concomitant occurrence of asthma and
atopic dermatitis [18]. However, two subsequent studies
failed to replicate the original SPINK5 findings for allergic
diseases [19,20]. Folster-Holst et al genotyped four non-
synonymous SNPs (Asp106Asn, Asn368Ser, Asp386Asn,
and Glu420Lys), and detected no association between
SPINK5 and atopic dermatitis in populations of Northern
German origin [20]. Jongepier H et al. failed to detect any
association between SPINK5 and asthma, atopic pheno-
types and atopic dermatitis in a Dutch population [19].
These discordant findings probably reflect different
genetic and environmental backgrounds in various popu-
lations. To determine whether nonsynonymous SNPs of
the SPINK5 are involved in the pathogenesis of asthma in
the Chinese Han population, we performed a case-control
study by genotyping four nonsynonymous SNPs in the
SPINK5. We did not detect any significant association
between these nonsynonymous SNPs and asthma in our
Chinese samples. With our sample size, we expected a
power of at least 80% in detecting an effect of OR ≥1.3 for
Table 4: Linkage disequilibrium coefficient (| D'|) among each 
polymorphism locus in SPINK5 gene*
Locus 1103A>G 1156G>A 1258G>A 2475G>T
-206G>A 0.628 0.769 0.616 0.680
1103A>G - 0.929 0.854 0.855
1156G>A - - 0.821 0.896
1258G>A 0.777
*The pairwise linkage disequilibrium analysis was conducted by online 
software SHEsis.
Table 5: The haplotype frequencies of the five polymorphisms in asthma patients and healthy controls.
Frequency
Haplotypes -206 1103 1156 1258 2475 Asthma control P*
Hap1 G A G A G 0.283 0.265 0.583
Hap2 G G A G T 0.275 0.260 0.691
Hap3 A G A G G 0.117 0.168 0.043
Hap4 G A G G G 0.112 0.109 0.896
Hap5 G G G G G 0.070 0.083 0.497
Hap6 G G A G G 0.031 0.021 0.370
Hap7 A G A G T 0.031 0.018 0.260
*The P value was calculated with the haplotype frequencies greater than 0.03 by online software-SHEsis.BMC Medical Genetics 2009, 10:59 http://www.biomedcentral.com/1471-2350/10/59
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each of these SNPs. Therefore, our failure to detect an
association for these 4 SNPs was not due to the sample
size. These results suggest that the polymorphisms in the
coding region of the SPINK5 are unlikely to contribute to
asthma risk in the Chinese Han population. However,
because our patients were ascertained for asthma, we
could not exclude a role of the coding SNPs of the SPINK5
in atopic dermatitis in our population.
The variations in the regulatory sequences of genes may
determine risks to common diseases by causing different
levels of expression. Therefore, the identification and
functional evaluation of polymorphisms in promoter
region are of great value in understanding the genetic sus-
ceptibility to asthma. In order to determine the role of the
SPINK5 promoter polymorphism in the pathogenesis of
asthma, we genotyped a promoter polymorphism, -
206G>A, in 422 asthma patients and 410 controls, and
found a marginal association. The frequency of allele G
was significantly higher in asthmatic patients than that in
controls (p = 0.022). To confirm the association, addi-
tional 267 asthma patients and 301 controls newly
recruited from the same hospital were genotyped, and the
-206G>A polymorphism remained significantly associ-
ated with asthma (P = 0.001), even after Bonferroni cor-
rection(adjusted P = 0.01). To our knowledge, this is the
first report of an association of -206G>A polymorphism
with asthma. We further examined the potential func-
tional role of this promoter polymorphism, and found
that the G to A substitution at -206 generated a GATA-3
transcription factor binding site.
Major transcription factors controlling Th1 and Th2 devel-
opment, such as T-box transcription factor and GATA3,
are possibly involved in asthma and atopic diseases.
GATA-3, a transcription factor specifically expressed in T
helper 2 (Th2) cells, plays a critical role in the differentia-
tion of Th2 cells from uncommitted CD4+ lymphocytes.
In addition, GATA-3 is essential for the expression of the
cytokines IL-4, IL-5 and IL-13 that mediate allergic inflam-
mation [23]. Our luciferase reporter assay confirmed that
SNP -206G>A is associated with the transcriptional activ-
ity of SPINK5. The G allele was associated with decreased
transcriptional activity of the SPINK5. The mechanism by
which the -206G>A SNP affects SPINK5 expression may
be explained by the potential differential transcription
factor binding of GATA binding factor, since -206G>A is
located at the core sequence of GATA binding factor bind-
ing site. Electrophoretic mobility shift assay confirmed
that the A to G substitution at -206 significantly reduced
the binding efficiency of nuclear proteins to this element.
Our data suggest that loss of GATA transcription factor
Effect of the -206 G>A on the transcription activity of the  SPINK5 promoter Figure 1
Effect of the -206 G>A on the transcription activity of 
the SPINK5 promoter. COS-7 cells or Hela cells were 
transiently cotransfected with pGL3/-206G or pGL3/-206A 
and pRL-TK vector. The relative luciferase activity of the 
SPINK5 reporter constructs is represented as the ratio of the 
firefly luciferase activity to that of Renilla. Each experiment 
was conducted in triplicate for each sample, and the results 
are expressed as mean ± SD for three independent experi-
ments. P value was determined by the Student's t test.
EMSA showing the physical binding of nuclear extract to  GATA binding site Figure 2
EMSA showing the physical binding of nuclear 
extract to GATA binding site. The arrow indicates 
DNA-protein complex formed when transcription factor 
binds to the target site. The retarded mobility of the oligonu-
cleotide was observed in the presence of nuclear extract, 
lane 2. The formation of DNA-protein complex was compet-
itively inhibited by 25- and 50-fold amount of unlabeled -
206A probe, lanes 3 and 4, but not by the same amount of 
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regulation with the -206G may decrease the SPINK5
expression and thereby potentially perturb the immuno-
suppressive function of LEKTI.
Conclusion
In summary, although previous studies indicated that
coding SNPs in the SPINK5  might be associated with
asthma, we were unable to detect an association between
the polymorphisms in the coding region of the SPINK5
and asthma risk in the Chinese Han population. How-
ever, we detected a significant association between -
206G>A polymorphism in SPINK5 promoter and asthma.
A single base substitution at -206 generated a functional
promoter element and altered the transcriptional activity
of the SPINK5.
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